Teplizumab's immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus.

Autor: Kokori, Emmanuel, Olatunji, Gbolahan, Ogieuhi, Ikponmwosa Jude, Aboje, John Ehi, Olatunji, Doyin, Aremu, Sikiru Ademola, Igwe, Stephen Chukwuemeka, Moradeyo, Abdulrahmon, Ajayi, Yusuf Ismaila, Aderinto, Nicholas
Zdroj: Clinical Diabetes & Endocrinology; 8/10/2024, Vol. 10 Issue 1, p1-12, 12p
Databáze: Complementary Index
Externí odkaz: